2020 IPO
Relay Therapeutics Stock
Analyze the movement of proteins inside human cells
Sign up today and learn more about Relay Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Relay Therapeutics Stock
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
Funding History
| September 2016 | $57.0M |
|---|---|
| December 2017 | $63.0M |
| December 2018 | $400M |
Management
President & CEO
Sanjiv Patel
Chief Scientific Officer and Co-Founder
Mark Murcko
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
